Variable | Group; mean (SD) | p value* | |
---|---|---|---|
Present study | Reference population | ||
Global health status and quality of life | 68.6 (15.1) | 70.8 (22.1) | 0.68 |
Physical functions | 74.1 (24.3) | 90.1 (16.7) | < 0.001 |
Functional handicap | 82.3 (25.3) | 88.0 (22.9) | 0.31 |
Emotional functions | 79.4 (17.5) | 78.7 (21.0) | 0.86 |
Cognitive functions | 90.2 (13.3) | 91.2 (17.0) | 0.81 |
Social functions | 94.1 (10.1) | 91.0 (19.4) | 0.51 |
Fatigue | 36.6 (20.7) | 17.1 (22.0) | < 0.001 |
Nausea and vomiting | 0.9 (4.0) | 2.8 (9.9) | 0.43 |
Pain | 20.0 (20.0) | 15.4 (24.4) | 0.44 |
Dyspnea | 11.7 (23.4) | 8.1 (20.3) | 0.47 |
Insomnia | 23.5 (30.7) | 16.4 (27.4) | 0.29 |
Loss of appetite | 9.8 (22.9) | 5.4 (16.0) | 0.26 |
Constipation | 19.6 (23.7) | 3.6 (13.7) | < 0.001 |
Diarrhea | 17.6 (29.2) | 2.8 (11.7) | < 0.001 |
Financial difficulties | 0 (0) | 6.0 (18.2) |
EORTC QLQ-C30 = European Organization for Research and Treatment of Cancer quality of life questionnaire; (18) SD = standard deviation.
↵* A t test was performed to compare the mean values of the present study with the reference values.